当前位置:首页 - 行情中心 - 东北制药(000597) - 财务分析 - 现金流量表

东北制药

(000597)

  

流通市值:79.20亿  总市值:80.20亿
流通股本:14.09亿   总股本:14.27亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,261,722,047.383,606,849,971.621,512,950,908.837,259,519,087.18
  收到的税费返还9,727,598.097,043,642.152,458,095.1518,601,190.83
  收到其他与经营活动有关的现金173,056,766.13119,775,485.0975,954,033.83312,470,397.65
  经营活动现金流入小计5,444,506,411.63,733,669,098.861,591,363,037.817,590,590,675.66
  购买商品、接受劳务支付的现金2,969,341,549.872,143,306,384.51869,794,866.483,877,759,625.28
  支付给职工以及为职工支付的现金775,199,096.99570,123,111.4336,937,014.141,003,139,832.02
  支付的各项税费318,031,496.56225,562,573.46123,779,080.87510,220,933.27
  支付其他与经营活动有关的现金1,002,731,544.23689,562,361.37291,709,382.381,440,709,163.88
  经营活动现金流出小计5,065,303,687.653,628,554,430.741,622,220,343.876,831,829,554.45
  经营活动产生的现金流量净额379,202,723.95105,114,668.12-30,857,306.06758,761,121.21
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额1,170,604.834,604.831,219.82,702,990
  投资活动现金流入小计1,170,604.834,604.831,219.82,702,990
  购建固定资产、无形资产和其他长期资产支付的现金61,590,908.3450,108,364.626,796,702.93159,425,992.57
  取得子公司及其他营业单位支付的现金---127,243,511.2
  支付其他与投资活动有关的现金14,000,000---
  投资活动现金流出小计75,590,908.3450,108,364.626,796,702.93286,669,503.77
  投资活动产生的现金流量净额-74,420,303.54-50,073,759.8-26,765,483.13-283,966,513.77
三、筹资活动产生的现金流量:
  取得借款收到的现金2,028,800,0001,818,800,0001,440,000,0001,772,200,000
  收到其他与筹资活动有关的现金7,322,677,799.164,912,421,414.51,813,729,501.8213,246,058,631.88
  筹资活动现金流入小计9,351,477,799.166,731,221,414.53,253,729,501.8215,018,258,631.88
  偿还债务支付的现金1,777,250,0001,571,450,000991,850,0002,447,629,999.99
  分配股利、利润或偿付利息支付的现金206,153,565.68191,008,884.8130,896,025.49206,138,041.64
  支付其他与筹资活动有关的现金7,300,720,815.84,951,877,230.662,294,634,183.5513,517,928,475.7
  筹资活动现金流出小计9,284,124,381.486,714,336,115.473,317,380,209.0416,171,696,517.33
  筹资活动产生的现金流量净额67,353,417.6816,885,299.03-63,650,707.22-1,153,437,885.45
四、汇率变动对现金及现金等价物的影响-8,550,203.22-4,941,908.96-1,595,224.129,678,799.74
五、现金及现金等价物净增加额363,585,634.8766,984,298.39-122,868,720.53-668,964,478.27
  加:期初现金及现金等价物余额2,097,991,603.942,097,991,603.942,097,991,603.942,766,956,082.21
  期末现金及现金等价物余额2,461,577,238.812,164,975,902.331,975,122,883.412,097,991,603.94
补充资料:
  净利润-124,262,718.49-423,282,321.89
  资产减值准备-43,517,471.18-123,022,277.68
  固定资产和投资性房地产折旧-247,650,398.12-502,912,009.99
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-247,650,398.12-502,912,009.99
  无形资产摊销-26,937,331.52-46,589,093.3
  长期待摊费用摊销-3,930,384.7-952,215.03
  处置固定资产、无形资产和其他长期资产的损失--181,512.23--6,192,436.61
  财务费用-29,254,824.43-95,570,177.45
  投资损失--2,871,681.33--5,160,420.26
  递延所得税--3,952,205.1-87,214,637.59
  其中:递延所得税资产减少--3,314,225.17--3,310,209.65
    递延所得税负债增加--637,979.93-90,524,847.24
  存货的减少-10,293,862.77-57,138,619.93
  经营性应收项目的减少--214,656,097.26--82,526,143.81
  经营性应付项目的增加--172,746,692.92--528,694,554.68
  其他--143,293.9-22,184,004.71
  不涉及现金收支的投资和筹资活动金额其他项目-6,740,766.46-43,755,259.14
  现金的期末余额-2,164,975,902.33-2,097,991,603.94
  减:现金的期初余额-2,097,991,603.94-2,766,956,082.21
  现金及现金等价物的净增加额-66,984,298.39--668,964,478.27
公告日期2025-10-282025-08-272025-04-292025-04-03
审计意见(境内)标准无保留意见
TOP↑